GFCR Grant Program (cancer clinical trial)
The Grant Program from the Gateway for Cancer Research funds early-phase clinical trials for any type of cancer, conducted at renowned research institutions worldwide. Grants are typically 2-5 years in duration with award amounts from 200,000 to 1.5 million USD. Applicants are required to first submit a letter of intent (LOI). Eligible applicants will be given 4-5 weeks to complete their full application. The next LOI closing date is January 31, 2023.
Challenge: Clinical Trials
Create or log-in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.